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Research
Epidemiologic studies have shown that the
prevalence of allergic diseases has increased at a
great rate, mainly among children and juve-
niles, over the past several decades (Beasley
et al. 2003). The etiology of allergy includes
genetic factors (e.g., sensitivity of hosts) and
environmental factors (e.g., allergen load, envi-
ronmental pollutants) (Burney et al. 1990; Peat
and Li 1999). In particular, environmental
chemicals may increase the potency of allergens
and thereby play a role in the development
and/or enhancement of allergic diseases
(Casillas et al. 1999). In fact, we and other
groups have previously reported that diesel
exhaust particles, which are major environmen-
tal pollutants in urban areas and contain a vari-
ety of organic chemicals such as polyaromatic
hydrocarbons, possess adjuvant activity (Diaz-
Sanchez 1997; Diaz-Sanchez et al. 1994; Heo
et al. 2001) and aggravate allergic airway
inﬂammation in murine models (Ichinose et al.
2004; Inoue et al. 2007; Miyabara et al. 1998;
Sadakane et al. 2002; Takano et al. 1997,
1998; Yanagisawa et al. 2006).
Di-(2-ethylhexyl) phthalate (DEHP),
another environmental chemical, has become
ubiquitous in developed countries. DEHP is
the most abundant phthalate plasticizer in
polyvinyl chloride (PVC) formulations,
including vinyl flooring, wall covering, food
containers, gloves, and infant toys. However,
DEHP is not chemically bound to PVC and
thus leaches out from the PVC items with time
and use. An epidemiologic study has shown
that DEHP in house dust is associated with
allergic asthma in children (Bornehag et al.
2004). In animal experiments, DEHP has dis-
played an adjuvant effect on allergen-related
immunoglobulin production (Thor Larsen
et al. 2001) and enhanced allergic responses,
including the production of interleukin-4
(IL-4) from CD4+ T cells (Lee et al. 2004).
More recently, we have shown that exposure
to DEHP aggravates atopic dermatitis-like
skin lesions related to mite allergen in young
male mice, as evidenced by macroscopic and
microscopic examinations. Furthermore, these
changes were consistent with the protein
expression of chemokines in the ear tissue in
overall trend (Takano et al. 2006).
In contrast, fetuses and infants, who are
believed to be one of the most sensitive popu-
lations to environmental chemicals (Colborn
et al. 1993; Holladay 1999; Holladay and
Smialowicz 2000), can be maternally exposed
to DEHP. In fact, DEHP and/or mono-(2-
ethylhexyl) phthalate (MEHP), a metabolite
of DEHP, have been detectable in human
cord blood and maternal plasma (Latini et al.
2003a, 2003b). In addition, MEHP has been
found in human breast milk (Calafat et al.
2004; Main et al. 2006) and in infant for-
mula (Mortensen et al. 2005; Sorensen
2006). Previous animal studies have suggested
that maternal exposure to phthalates during
fetal and/or neonatal periods may cause
reproductive and developmental toxicities in
offspring due to their actions as endocrine-
disrupting chemicals (EDCs) (Borch et al.
2006; Kim et al. 2004). 
In the present study, we examined
whether maternal exposure to DEHP in
NC/NgaTndCrj (NC/Nga) mice during fetal
and/or neonatal periods affects atopic
dermatitis-like skin lesions related to mite
allergen in offspring.
Materials and Methods
Animals. We purchased 8-week-old male and
female NC/Nga mice from Charles River
Japan (Osaka, Japan). They were fed a com-
mercial diet (CE-2; Japan Clea Co., Tokyo,
Japan) and water ad libitum and housed in an
animal facility maintained at 22–26°C with
40–69% humidity and a 12/12-hr light/dark
cycle. All mice were treated humanely with
regard for alleviation of suffering in accordance
with guidelines of the National Institute for
Environmental Studies for animal experi-
ments. All protocols involving mice were
approved by the institutional review board.
Study protocols. Experiment 1: maternal
exposure to DEHP during fetal periods. We
divided male and female mice (8 weeks of
age) into seven experimental groups and kept
them under speciﬁc-pathogen-free (SPF) con-
ditions in an animal facility for 1 week. We
mated four male and ﬁve female mice in each
cage under SPF conditions for 1 week
(days 0–7) and then separated male and
female mice. We administered DEHP by
intraperitoneal injection at a dose of 0.8, 4,
20, or 100 µg dissolved in 0.1 mL olive oil
(Wako Pure Chemical Industries, Ltd.,
Osaka, Japan) to the dams in four groups on
days 0, 7, and 14 (Figure 1). These doses
were equivalent to daily DEHP intake of 4.8,
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BACKGROUND: Di-(2-ethylhexyl) phthalate (DEHP) has been widely used in polyvinyl chloride
products and is ubiquitous in developed countries. Although maternal exposure to DEHP during
fetal and/or neonatal periods reportedly affects reproductive and developmental systems, its effects
on allergic diseases in offspring remain to be determined.
OBJECTIVES: In the present study, we examined whether maternal exposure to DEHP during fetal
and/or neonatal periods in NC/Nga mice affects atopic dermatitis-like skin lesions related to mite
allergen in offspring.
METHODS: We administered DEHP at a dose of 0, 0.8, 4, 20, or 100 µg/animal/week by intra-
peritoneal injection into dams during pregnancy (gestation days 0, 7, and 14) and/or lactation
(postnatal days 1, 8, and 15). Eight-week-old male offspring of these treated females were injected
intradermally with mite allergen into their right ears. We then evaluated clinical scores, ear thicken-
ing, histologic ﬁndings, and protein expression of eotaxin in the ear. 
RESULTS: Maternal exposure to a 100-µg dose of DEHP during neonatal periods, but not during
fetal periods, enhanced atopic dermatitis-like skin lesions related to mite allergen in males. The
results were concomitant with the enhancement of eosinophilic inﬂammation, mast cell degranula-
tion, and protein expression of eotaxin in overall trend.
CONCLUSION: Maternal exposure to DEHP during neonatal periods can accelerate atopic dermatitis-
like skin lesions related to mite allergen in male offspring, possibly via T helper 2 (TH2)-dominant
responses, which can be responsible, at least in part, for the recent increase in atopic dermatitis.
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[Online 9 April 2008]24, 120, and 600 µg/kg body weight per day.
Two groups of animals received only olive oil
and served as vehicle controls, and one group
received no treatment (untreated). We
checked breeding cages daily for births.
Experiment 2: maternal exposure to
DEHP during neonatal periods. We divided
male and female mice (8 weeks of age) into
seven experimental groups and kept them
under SPF conditions in an animal facility for
1 week. We mated four male and ﬁve female
mice in each cage under SPF conditions for
1 week and then separated male and female
mice. We checked breeding cages daily for
births. We then administered DEHP at a
dose of 0.8, 4, 20, or 100 µg by intra-
peritoneal injection to dams in four groups
on days 1, 8, and 15 after birth (Figure 1).
Two groups of animals received only olive oil
and served as vehicle controls. The untreated
group received no treatment.
Mite allergen treatment in pups. In both
experiments, at least one litter was included in
each experimental group. We kept litters with
dams until weaning at 4 weeks of age. While
under anesthesia with 4% halothane (Takeda
Chemical Industries, Ltd., Osaka, Japan),
8-week-old males (22–25 g) were injected
intradermally with saline (one group) or 5 µg
(10 µL) of mite allergen extract [Dermato-
phagoides pteronyssinus (Dp); Cosmo Bio LSL,
Tokyo, Japan] dissolved in saline (ﬁve groups)
on the ventral side of their right ears on treat-
ment days 0, 2, 4, 7, 9, 11, 14, and 16
(Figure 1). Twenty-four hours after each
intradermal injection, we measured ear thick-
ness with a gauge (Ozaki Mfg. Co. Ltd.,
Osaka, Japan) and evaluated clinical scores for
skin dryness, eruption, and wound, graded
from 0 to 3 (0, no symptoms; 1, mild; 2,
moderate; 3, severe). The untreated group
received no Dp treatment.
Histologic evaluation. Animals were sacri-
ﬁced by etherization 24 hr after the last intra-
dermal injection (day 17). Right ears of males
were removed and fixed in 10% phosphate-
buffered formalin (pH 7.2), embedded in
parafﬁn, cut into 3-µm sections, and stained
with hematoxylin/eosin (H&E) and toluidine
blue (pH 4.0). We performed histologic
analyses using an Olympus AX80 microscope
(Olympus Corp., Tokyo, Japan) and mea-
sured the length of the cartilage in each speci-
men using an Olympus VM-30 video
micrometer. The infiltration of eosinophils
and mast cells were morphometrically evalu-
ated as the number of cells per millimeter of
cartilage. We also evaluated the degranulation
of mast cells as not degranulated (0%), mildly
degranulated (0–50%), and severely degranu-
lated (> 50%) (Takano et al. 2006).
ELISA. Right ears of males were removed
24 hr after the last intradermal injection; ears
were then homogenized and centrifuged as
previously described by Takano et al. (1997).
We conducted enzyme-linked immunosor-
bent assays (ELISAs) for eotaxin (R&D
Systems, Minneapolis, MN, USA) in the ear
tissue supernatants according to the manufac-
turer’s instructions. The detection limit for
eotaxin was < 3 pg/mL.
Statistical analysis. We analyzed differences
between the groups using Dunnett’s or Steel
multiple comparison tests using Excel Statistics
2006 statistical software (Social Survey
Research Information Co., Ltd., Tokyo, Japan).
We considered p-values < 0.05 to be signiﬁcant,
and data are reported as mean ± SE.
Results
Maternal DEHP exposure during fetal periods
and atopic dermatitis-like skin lesions in off-
spring. To evaluate the effects of maternal
exposure to DEHP during fetal periods on
atopic dermatitis-like skin lesions related to
mite allergen in males, we examined clinical
scores, including dryness, eruption, wound,
edema, and ear thickening in males in the pres-
ence or absence of mite allergen. Treatment
with mite allergen signiﬁcantly enhanced ear
thickening (p < 0.01; Figure 2) and clinical
scores (p < 0.01; see Supplemental Material,
Figure 1, available online at http://www.
ehponline.org/members/2008/11191/
suppl.pdf) compared with untreated or saline
groups from day 5. However, maternal expo-
sure to DEHP during fetal periods did not
show signiﬁcant enhancing effects in the pres-
ence of allergen compared with exposure to
vehicle alone. We found no change in the no
treatment and saline treatment groups.
Maternal DEHP exposure during neona-
tal periods and atopic dermatitis-like skin
lesions in offspring. To evaluate the effects of
maternal exposure to DEHP during neonatal
periods on atopic dermatitis-like skin lesions
related to mite allergen in males, we examined
ear thickening and clinical scores. Treatment
with mite allergen signiﬁcantly enhanced ear
thickening (p < 0.01; Figure 3A) and clinical
scores (p < 0.01; see Supplemental Material,
Figure 2, available online at http://www.
ehponline.org/members/2008/11191/suppl.
pdf) compared with untreated or saline groups
from day 5. From day 12, maternal exposure
to 100 µg DEHP significantly increased ear
thickening (Figure 3A) and clinical scores (see
Supplemental Material, Figure 2, available
online at http://www.ehponline.org/members/
2008/11191/suppl.pdf) in males compared
with vehicle exposure in the presence of mite
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Figure 1. Experimental protocol for maternal exposure to DEHP during fetal and/or neonatal periods and
for allergen sensitization in offspring. Dp, Dermatophagoides pteronyssinus extract. 
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Figure 2. Effect of maternal exposure to DEHP during
fetal periods on atopic dermatitis-like skin lesions
in offspring shown by ear thickening 24 hr after
each intradermal injection of Dp. Data shown are
mean ± SE of 7–12 animals per group. 
**p < 0.01, Dp-treated groups compared with untreated
group and saline (+ vehicle) groups. 
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**allergen. In macroscopic examination, we
observed edema, dryness, excoriation, and
crust at the dorsal site of allergen-injected ears
in males (Figure 3C). Furthermore, these ﬁnd-
ings were prominent and were often accompa-
nied by severe hemorrhage and erosion in the
presence of maternal exposure to DEHP dur-
ing neonatal periods (Figure 3D). We found
no change in untreated (data not shown) or
saline groups (Figure 3B). 
Maternal DEHP exposure during neo-
natal periods and histologic changes in the skin
related to mite allergen in offspring. To deter-
mine the effects of maternal exposure to
DEHP during neonatal periods on histologic
changes of the skin related to mite allergen in
males, we evaluated the skin specimens stained
with H&E (Figure 4A–D) or toluidine blue
(Figure 4E–H) 24 hr after the last intradermal
inoculation. We found no pathologic altera-
tions with no treatment or saline treatment
(Figure 4B,4F). Treatment with mite allergen
(Figure 4A,C) enhanced the infiltration of
eosinophils into the skin lesions compared with
saline treatment or no treatment (p < 0.01).
Further, maternal exposure to 100 µg DEHP
(Figure 4D) during neonatal periods caused
more prominent eosinophilic inflammation
than did exposure to vehicle in the presence of
allergen [Figure 4A; p < 0.01 for Dp (+ DEHP
100 µg) group vs. Dp (+ vehicle) group]. In
overall trend, these changes were consistent
with the severity of mast cell degranulation
[Figure 4E–H, p < 0.01 for Dp (+ DEHP
100 µg) group vs. untreated group, saline
(+ vehicle) group, and Dp (+ vehicle) group].
Maternal DEHP exposure during neo-
natal periods and protein expression of
eotaxin in the skin related to mite allergen in
offspring. We evaluated the protein expression
of eotaxin in the ear 24 hr after the ﬁnal intra-
dermal inoculation to elucidate the mecha-
nism of the enhancing effects of maternal
exposure to DEHP during neonatal periods
on atopic dermatitis-like skin lesions related
to mite allergen in males. Treatment with
mite allergen increased the expression of
eotaxin compared with untreated or saline
groups (Figure 5; p < 0.05). Furthermore, in
males treated with mite allergen, maternal
exposure to 100 µg DEHP during neonatal
periods markedly enhanced the protein
expression of eotaxin compared with vehicle
exposure (p < 0.05). In addition, DEHP at a
dose of 4 or 20 µg tended to enhance the
local expression of eotaxin.
Discussion
The present study shows that maternal expo-
sure of mice to DEHP during neonatal periods
aggravates atopic dermatitis-like skin lesions
related to mite allergen in male offspring. The
enhancing effects are nearly paralleled by those
on eosinophilic inflammation, mast cell
degranulation, and local expression of eotaxin.
In contrast, we observed no signiﬁcant enhanc-
ing effects after maternal exposure to DEHP
during fetal periods.
DEHP, the most commonly used plasti-
cizer in ﬂexible PVC formulations, is a ubiqui-
tous environmental toxicant. Thus, the general
population can be exposed to DEHP in food,
water, and air via ingestion or inhalation. In
particular, fetuses and infants can be mater-
nally exposed to DEHP at early life stages
(Calafat et al. 2004; Latini et al. 2003a, 2003b;
Main et al. 2006). Previous studies have sug-
gested that maternal exposure to phthalates
during fetal and/or neonatal periods can
adversely affect reproduction and development
by acting as EDCs in animals and humans
(Borch et al. 2006; Kim et al. 2004; Marsee
et al. 2006). However, whether maternal expo-
sure to DEHP and/or its metabolites during
fetal and/or neonatal periods can affect allergic
diseases, including atopic dermatitis in off-
spring, has not been elucidated.
The developing immune system, which
depends chiefly on mother-derived humoral
immunity during embryonic/fetal periods and
acquired cellular and humoral immunity dur-
ing neonatal periods, can be vulnerable to
environmental toxicants such as EDCs
(Holladay 1999; Holladay and Smialowicz
2000). Epidemiologic studies have indicated
that exposure to EDCs, such as dioxins and
polychlorinated biphenyls, during human
development can affect the immune system
(Dallaire et al. 2004; Nagayama et al. 1998;
Weisglas-Kuperus et al. 1995). In experimen-
tal studies, prenatal/perinatal exposure to
2,3,7,8-tetrachlorodibenzo-p-dioxin and
bisphenol A can modulate immune responses
in rodents (Gehrs et al. 1997; Vorderstrasse
et al. 2006; Yoshino et al. 2004). On the other
hand, few studies have exposed experimental
animals to environmental chemicals only dur-
ing postnatal periods. In the present study,
maternal exposure to DEHP only during
neonatal periods enhanced atopic dermatitis-
like skin lesions related to mite allergen in
male offspring. In contrast, maternal exposure
to DEHP during fetal periods did not affect
the aggravation of atopic dermatitis-like skin
lesions related to mite allergen. Together,
these data indicate that maternal exposure to
DEHP may contribute to the modulation of
adaptive immunity in offspring rather than
mother-derived immunity in our model. This
hypothesis is supported by our previous study
in which DEHP exposure in young subjects
enhanced atopic dermatitis-like skin lesions
related to mite allergen (Takano et al. 2006).
Our present and previous results thus impli-
cate exposure to environmental chemicals dur-
ing neonatal periods in the enhancement of
allergen-related inﬂammation in offspring.
DEHP reportedly induces reproductive
and developmental problems predominantly
in male rodents (Borch et al. 2006; Kim et al.
2004). Also, a recent epidemiologic study
has suggested that estimated daily phthalate
Yanagisawa et al.
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Figure 3. Effect of maternal exposure to DEHP during neonatal periods on atopic dermatitis-like skin
lesions in offspring shown by ear thickening 24 hr after each intradermal injection of Dp (A) and macro-
scopic features 24 hr after the last injection (B–D). (B) Saline (+ vehicle). (C) Dp (+ vehicle). (D) Dp (+ DEHP
100 µg). Data shown are mean ± SE of 12 animals per group. 
**p < 0.01, Dp-treated groups compared with untreated and saline (+ vehicle) groups. #p < 0.01, Dp (+ DEHP 100 µg) group
compared with Dp (+ vehicle) group. For B–D, bar = 5 mm. 
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#exposure is associated with reduced anogenital
distance in male infants (Marsee et al. 2006).
Our present experiments also showed that
maternal exposure to DEHP during fetal and
neonatal periods did not affect atopic der-
matitis-like symptoms in females (data not
shown). The present results may demonstrate
the existence of sex differences in the sensitiv-
ity to DEHP during neonatal periods in the
case of atopic dermatitis, similar to differences
in aromatase activity described by Andrade
et al. (2006). 
In the present study, maternal exposure to
DEHP during neonatal periods aggravates
atopic dermatitis-like skin lesions in male off-
spring at a dose about 30-fold lower (100 µg/
animal/week ≈ 600 µg/kg/day) than the no
observed adverse effect level (19 mg/kg/day),
which was determined on the basis of histo-
logic changes in the rodent liver (Carpenter
et al. 1953). Phthalate metabolites have been
found in human breast milk (Calafat et al.
2004; Main et al. 2006) and in infant formula
(Mortensen et al. 2005; Sorensen 2006).
Several studies have estimated the average
daily intake of DEHP in infants 0–3 months
of age at 13 µg/kg/day for infant formula and
21 µg/kg/day for breast milk (Latini et al.
2004). On the other hand, there are differ-
ences in disposition kinetics of DEHP and its
biological metabolite MEHP between intra-
peritoneal and oral administration (Pollack
et al. 1985). In addition, oral exposure of rat
dams to DEHP at high doses (2 g/kg for
5 days) during lactation can lead to plasma
levels of DEHP (216 ± 23 µg/mL, mean ± SE)
and MEHP (25 ± 6 µg/mL) in suckling pups
(Dostal et al. 1987). To our knowledge, how-
ever, no previous studies have determined the
differences in the plasma levels of suckling
pups and/or breast milk levels of DEHP and
its metabolites after maternal exposure to
DEHP via different routes during neonatal
periods. Thus, in the next stage of research, we
should try to quantify the concentration of
DEHP and/or its metabolites in the breast
milk and/or plasma levels of suckling pups
after intraperitoneal or oral administration and
investigate the effects of oral administration at
the level of human exposure of DEHP. 
In the present study we found that mater-
nal exposure to DEHP at a dose of 100 µg
during neonatal periods increased the expres-
sion of eotaxin in the ear tissue in the presence
of allergen. The results were concomitant with
the recruitment of eosinophils into skin lesions
and with mast cell degranulation. Eosinophils
play a prominent proinflammatory role in a
broad range of allergic diseases, including
atopic dermatitis. Eotaxin is important in the
early recruitment of eosinophils after allergen
challenge. Eotaxin is reportedly increased in
the blood of patients with atopic dermatitis
(Hossny et al. 2001; Jahnz-Rozyk et al. 2005)
and expressed in lesions of human atopic der-
matitis (Yawalkar et al. 1999). CCR3, a prin-
cipal receptor for eotaxin, has been found to
be essential for eosinophil recruitment into
murine skin lesions caused by repeated aller-
gen sensitization (Ma et al. 2002). In addition,
tryptase/chymase double-positive mast cells
express CCR3 and are attracted by eotaxin
(Ochi et al. 1999; Romagnani et al. 1999).
Also, mast cell–deficient mice have shown
reduced lung eosinophilia after eotaxin
administration compared with wild-type mice
DEHP exposure during neonatal periods enhances atopic dermatitis
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Figure 4. Histologic changes in the ear 24 hr after the last intradermal injection of Dp. The infiltration of
eosinophils (A) and mast cells (E) were morphometrically evaluated as the number of cells per millimeter
of cartilage. We also evaluated the degranulation of mast cells as not degranulated (0%), mildly degranu-
lated (0–50%), and severely degranulated (> 50%). (B–D) and (F–H) show histologic ﬁndings of the saline
(+ vehicle) (B, F), Dp (+ vehicle) (C, G), and Dp (+ DEHP 100 µg) (D, H) groups; tissues were stained with
H&E (B–D) or toluidine blue (F–H). In A and E, data shown are mean ± SE of four animals per group. 
*p < 0.05, Dp-treated groups compared with untreated and saline (+ vehicle) groups. **p < 0.01, Dp-treated groups com-
pared with untreated and saline (+ vehicle) groups. #p < 0.01, Dp (+ DEHP 100 µg) group compared with Dp (+ vehicle)
group. For B–D, bar = 100 µg; for inset in D, bar = 10 µm; for F–H, bar = 50 µm. 
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after allergen sensitization (Das et al. 2006).
Interestingly, the present study shows that
DEHP at a dose of 4 or 20 µg tended to
enhance the local expression of eotaxin. These
findings indicate that maternal exposure to
DEHP at doses < 100 µg during neonatal
periods can prompt the manifestation of
atopic dermatitis in offspring at the molecular
level. In contrast, mite allergen treatment
induced the expression of T helper 2 (TH2)-
type cytokines, including IL-4, IL-5, IL-13,
and RANTES, compared with no treatment or
saline treatment, whereas maternal exposure to
DEHP during neonatal periods did not signiﬁ-
cantly enhance the effects (data not shown).
Thus, eotaxin might be a critical molecule in
our model.
In our present model using NC/Nga mice,
mite allergen treatment signiﬁcantly elevated
the production of total IgE and allergen-speciﬁc
IgG1 in serum, increased the number of sub-
mandibular lymph node cells, and enhanced
cell proliferation of submandibular lymph node
cells in the presence of allergen stimulation
ex vivo (data not shown). These results suggest
that allergen-speciﬁc responses play critical roles
in the present model of atopic dermatitis-like
skin lesions. In addition, maternal exposure to
DEHP during neonatal periods enhanced
effects related to mite allergen in offspring,
including eotaxin expression, eosinophilic
inﬂammation, and mast cell degranulation, all
of which are typically shown in allergen-related
TH2-dominant responses and/or inﬂammation
(Heishi et al. 2003; Sasakawa et al. 2001; Yagi
et al. 2002; Yamashita et al. 2007). Taken
together, maternal exposure to DEHP during
neonatal periods can accelerate allergen-related
inflammation possibly via TH2-dominant
responses in our model.
Conclusion
In the present study using a murine model, we
have shown that maternal exposure to DEHP
during neonatal periods aggravates atopic der-
matitis-like skin lesions related to mite aller-
gen in male offspring. The enhancing effects
may be mediated through the enhanced
expression of eotaxin. Our results support the
novel hypothesis that maternal exposure to
DEHP during neonatal periods via breast milk
and/or infant formula may be responsible, at
least in part, for the recent increase in atopic
dermatitis in offspring. To further clarify this
hypothesis, we should examine breast milk
levels and/or suckling pup plasma levels of
DEHP and/or its metabolites and the time
course of cytokine expression in our model, as
well as in a model using oral administration of
DEHP. Furthermore, epidemiologic studies
should determine the relationships between
exposure to DEHP via breast milk and/or
infant formula and the manifestation of atopic
dermatitis in offspring.
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